185 related articles for article (PubMed ID: 15826413)
1. Disease-centred advice for patients with superficial transitional cell carcinoma of the bladder.
Dearing J
Ann R Coll Surg Engl; 2005 Mar; 87(2):85-7. PubMed ID: 15826413
[TBL] [Abstract][Full Text] [Related]
2. Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder.
Fleshner N; Garland J; Moadel A; Herr H; Ostroff J; Trambert R; O'Sullivan M; Russo P
Cancer; 1999 Dec; 86(11):2337-45. PubMed ID: 10590376
[TBL] [Abstract][Full Text] [Related]
3. Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer.
Chen CH; Shun CT; Huang KH; Huang CY; Tsai YC; Yu HJ; Pu YS
BJU Int; 2007 Aug; 100(2):281-6; discussion 286. PubMed ID: 17419696
[TBL] [Abstract][Full Text] [Related]
4. Cigarette smoking and drinking water source: correlation with clinical features and pathology of superficial bladder carcinoma.
Serretta V; Altieri V; Morgia G; Allegro R; Ruggirello A; Di Lallo A; Carrieri G; Melloni D;
Urol Int; 2009; 82(3):318-23. PubMed ID: 19440021
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
Yang TB; Zeng FH; Sun ZQ
Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
[TBL] [Abstract][Full Text] [Related]
6. Patients with superficial transitional cell carcinoma of the bladder and their smoking status.
Smith JA
Cancer; 1999 Dec; 86(11):2192-4. PubMed ID: 10590355
[No Abstract] [Full Text] [Related]
7. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.
Jancke G; Damm O; Rosell J; Jahnson S
Scand J Urol Nephrol; 2008; 42(5):417-21. PubMed ID: 18609266
[TBL] [Abstract][Full Text] [Related]
8. Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology.
Raman JD; Ng CK; Boorjian SA; Vaughan ED; Sosa RE; Scherr DS
BJU Int; 2005 Nov; 96(7):1031-5. PubMed ID: 16225523
[TBL] [Abstract][Full Text] [Related]
9. The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer.
Divrik RT; Sahin A; Altok M; Unlü N; Zorlu F
J Urol; 2007 Sep; 178(3 Pt 1):802-6; discussion 806. PubMed ID: 17632171
[TBL] [Abstract][Full Text] [Related]
10. The causal role of cigarette smoking in bladder cancer initiation and progression, and the role of urologists in smoking cessation.
Strope SA; Montie JE
J Urol; 2008 Jul; 180(1):31-7; discussion 37. PubMed ID: 18485400
[TBL] [Abstract][Full Text] [Related]
11. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
Chou EC; Lin AT; Chen KK; Chang LS
Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
[TBL] [Abstract][Full Text] [Related]
12. Ta T1 low and intermediate transitional cell carcinoma of the bladder: recurrence rates and the timing of check cystoscopies within the first year.
Guney S; Guney N; Canogullari Z; Ergenekon E
Urol Int; 2008; 80(2):124-8. PubMed ID: 18362479
[TBL] [Abstract][Full Text] [Related]
13. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
[TBL] [Abstract][Full Text] [Related]
14. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
Cai T; Nesi G; Boddi V; Mazzoli S; Dal Canto M; Bartoletti R
Oncol Rep; 2006 Aug; 16(2):329-34. PubMed ID: 16820911
[TBL] [Abstract][Full Text] [Related]
16. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients.
Li CC; Chang TH; Wu WJ; Ke HL; Huang SP; Tsai PC; Chang SJ; Shen JT; Chou YH; Huang CH
Eur Urol; 2008 Nov; 54(5):1127-34. PubMed ID: 18243511
[TBL] [Abstract][Full Text] [Related]
17. Smoking knowledge assessment and cessation trends in patients with bladder cancer presenting to a tertiary referral center.
Guzzo TJ; Hockenberry MS; Mucksavage P; Bivalacqua TJ; Schoenberg MP
Urology; 2012 Jan; 79(1):166-71. PubMed ID: 22030373
[TBL] [Abstract][Full Text] [Related]
18. Are patients aware of the association between smoking and bladder cancer?
Nieder AM; John S; Messina CR; Granek IA; Adler HL
J Urol; 2006 Dec; 176(6 Pt 1):2405-8; discussion 2408. PubMed ID: 17085114
[TBL] [Abstract][Full Text] [Related]
19. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
Raman JD; Sosa RE; Vaughan ED; Scherr DS
Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
Soga N; Arima K; Sugimura Y
Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
